Morgan Stanley Bioceres Crop Solutions Corp. Transaction History

Morgan Stanley

$1.36 Trillion
Q1 2025

A detailed history of Morgan Stanley transactions in Bioceres Crop Solutions Corp. stock. As of the latest transaction made, Morgan Stanley holds 95,651 shares of BIOX stock, worth $467,733. This represents 0.0% of its overall portfolio holdings.

Number of Shares

95,651

Previous 109,785 12.87%

Holding current value

$467,733

Previous $667,000 34.48%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$3.94 - $7.22 $55,687 - $102,047	-14,134 Reduced 12.87%	95,651 $437,000
Q4 2024 Feb 14, 2025	BUY	$6.04 - $7.86 $242,421 - $315,468	40,136 Added 57.63%	109,785 $667,000
Q2 2024 May 14, 2025	SELL	$10.53 - $13.18 $422,632 - $528,992	-40,136 Reduced 36.56%	69,649 $780,000
Q2 2024 Oct 17, 2024	SELL	$10.53 - $13.18 $416,303 - $521,071	-39,535 Reduced 36.21%	69,649 $780,000
Q2 2024 Aug 14, 2024	SELL	$10.53 - $13.18 $416,303 - $521,071	-39,535 Reduced 36.21%	69,649 $780,000
Q1 2024 Oct 17, 2024	BUY	$12.47 - $13.86 $493,001 - $547,955	39,535 Added 56.76%	109,184 $1.38 Million
Q1 2024 Aug 16, 2024	BUY	$12.47 - $13.86 $894,310 - $993,997	71,717 Added 191.41%	109,184 $1.38 Million
Q1 2024 May 15, 2024	BUY	$12.47 - $13.86 $894,310 - $993,997	71,717 Added 191.41%	109,184 $1.38 Million
Q4 2023 Aug 16, 2024	SELL	$10.33 - $13.84 $332,440 - $445,398	-32,182 Reduced 46.21%	37,467 $514,000
Q4 2023 Feb 13, 2024	BUY	$10.33 - $13.84 $364,659 - $488,565	35,301 Added 1629.78%	37,467 $514,000
Q3 2023 Nov 15, 2023	SELL	$10.79 - $13.52 $5,761 - $7,219	-534 Reduced 19.78%	2,166 $24,000
Q2 2023 Aug 14, 2023	SELL	$9.86 - $13.74 $99,221 - $138,265	-10,063 Reduced 78.85%	2,700 $36,000
Q1 2023 May 15, 2023	SELL	$10.63 - $12.78 $18,283 - $21,981	-1,720 Reduced 11.88%	12,763 $148,000
Q4 2022 Feb 14, 2023	SELL	$11.11 - $14.49 $11,909 - $15,533	-1,072 Reduced 6.89%	14,483 $174,000
Q3 2022 Nov 14, 2022	BUY	$9.44 - $14.99 $50,324 - $79,911	5,331 Added 52.14%	15,555 $202,000
Q2 2022 Oct 27, 2022	SELL	$11.39 - $15.12 $27,279 - $36,212	-2,395 Reduced 18.98%	10,224 $140,000
Q2 2022 Aug 15, 2022	SELL	$11.39 - $15.12 $27,279 - $36,212	-2,395 Reduced 18.98%	10,224 $140,000
Q1 2022 Oct 27, 2022	BUY	$11.07 - $14.89 $26,512 - $35,661	2,395 Added 23.43%	12,619 $172,000
Q1 2022 May 13, 2022	BUY	$11.07 - $14.89 $27,675 - $37,225	2,500 Added 24.71%	12,619 $172,000
Q4 2021 Feb 14, 2022	BUY	$12.76 - $16.0 $31,900 - $40,000	2,500 Added 32.81%	10,119 $143,000
Q3 2021 Nov 15, 2021	BUY	$12.4 - $14.32 $94,475 - $109,104	7,619 New	7,619 $103,000

Others Institutions Holding BIOX

# of Institutions

Shares Held

14M

Call Options Held

136K

Put Options Held

23.4K

View Full List

About Bioceres Crop Solutions Corp.

Ticker BIOX
Exchange NASDAQ
Sector Basic Materials
Industry Agricultural Inputs
Shares Outstandng 61,918,400
Market Cap $303M
Description
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through three segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment develops and commercializes seed technology, biotechnological events, germplasm, and seed treatments. ...

More about BIOX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account